General Information

Targeting Microbiota 2024 Speakers

Keynote Speech Day 1  Phage Therapy: A New Era of “Old” Concept for “Microbiome” Health Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia

Keynote Speech Day 2  The Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris, France

Drug Effects of Gut Microbiota in Humans: Clinical Consequences Carmelo Scarpignato, Chinese University of Hong Kong, China

Does the Microbiome Control Cravings and Addictive Behavior of their Host: A New Prospective and Hope for Treating Addiction Steven R. Gundry, The Centers for Restorative Medicine, USA

Mythbusting Our Microbiome Alan Walker, University of Aberdeen, United Kingdom

Probiotics & Health: How to Select the Right Strain? Andreas Schwiertz, Institute of Microecology, Germany

Gut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed José Manuel Fernández-Real, Institut d'Investigació Biomèdica de Girona, Hospital Trueta de Girona, and University of Girona, Spain

The Small Intestinal Microbiota: A Hidden Player in Human Health and Disease Pascale Vonaesch, University of Lausanne, Switzerland

Microbiota-Derived Extracellular Vesicles: Bridging Mother and Fetus Justus Reunanen, University of Oulu, Finland

Deciphering the role of the Oral-Placental and Vaginal-Placental Microbiome Axes in Preterm Birth Souhaila Al Khodor, Sidra Medicine, Qatar

Male Fertility and Gut Microbiota: Current Knowledge and Future Directions Cristian O'Flaherty, McGill University, Canada

Gut Microbiome, Obesity and Diabetes Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan

Microbial Phenotypes in Obesity: Implications for Precision Nutrition Ellen Blaak, Maastricht University, Netherlands

Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy Martin Loessner, ETH Zurich, Switzerland

Prospects for Leveraging the Microbiota as Medicine for Hypertension Bina Joe, University of Toledo, USA

Using Roseoflavin, a Natural Riboflavin Analogue, to Modify the Human Microbiota Markus Egert, Furtwangen University, Germany

Culturing the Complexity of Intestinal Microbiota In-Vitro in Bac3Gel Daniela Pacheco, CTO & Founder of Bac3Gel, Portugal

Sophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease Koen Venema, Editor-in-chief of Beneficial Microbes, Netherlands

Gut Microbiota in Early Life: Impact on Neurodevelopmental Outcomes Rochellys Diaz Heijtz, Karolinska Institutet, Sweden

Gut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience Patrick C. H. Hsieh, Academia Sinica, Tawian

Gut Microbiome Signatures in Irritable Bowel Syndrome Simone Domenico Guglielmetti, Università degli Studi di Milano-Bicocca, Italy

From Microbiomes and (Meta)genomes to the Lab and Back - Identification, Production and Application of Bacteriocins Christian Riedel, University of Ulm, Germany

From Mechanisms to Medicine: Explore All Abstracts from Targeting Microbiota 2025

We are pleased to announce that the Abstracts Book of the 12th World Congress on Targeting Microbiota is now available. The abstracts reflect the scientific richness and diversity of this year’s edition, from microbiota–host communication mechanisms to clinical metagenomics, AI analytics, nutrition, aging, and microbiome-based therapies.This collection showcases the collaborative effort of the global microbiome community, uniting over 187 participants from 23 countries — representing both academic excellence and industrial innovation.

Purchase Abstracts Book
Abstract book is included Congress in-person & online attendee ticket.

Final Agenda

Targeting Microbiota 2024 Sessions

Day 1 - Monday, October 14, 2024

Key note Speaker: 
Targeting Gut and Skin by Phages: Towards the Next Clinical Revolution

Session 1:
Microbiota in Health & Disease: Advancements & Perspectives

   a. Fecal Microbiota Transplantation (FMT): Clinical Applications, Regulation and Insights

   b. Probiotics in Health & Disease Management: Strain-Specific Efficacy and Challenges

   c. Metabolites Analysis: Characterization and Synthetic Approaches for Clinical and Nutritional Research

   d. Phage Therapy: Emerging Applications and Challenges

   e. Extracellular Vesicles and Exosomes: Where is the Target?

Day 2 - Tuesday, October 15, 2024 

Session 2:
Probiotic & Prebiotic Prescribing Practices: How to Empower Medical Actors to Improve Patients' Health?

How Can We Integrate the Latest Research for Optimal Results?
What Are the Challenges and Opportunities in Current Probiotic Use?
How Can Next-Generation Probiotics Transform Patient Care?

This specialized workshop will target medical professionals including cardiologists, neurologists, oncologists and others.

International Society of Microbiota
Press Releases | LinkedIn | Facebook